Strive offers an asymmetric but highly volatile Bitcoin treasury proxy, with 23,156 BTC and a debt-free preferred-equity model offset by a 2.09x mNAV premium and severe crypto-regulatory risk.
Strive, Inc. (Nasdaq: ASST), operating under its primary brand Strive Asset Management, represents a structurally unique financial services enterprise [cite: 1, 2]. The company represents the first publicly traded asset management Bitcoin treasury company, created via a reverse merger on September 12, 2025, between Asset Entities Inc. and Strive Enterprises, Inc. [cite: 2, 3]. Headquartered in Columbus, Ohio, and with corporate offices in Dallas, Texas, the company operates as an SEC-registered investment adviser alongside its recently integrated medical diagnostic subsidiary [cite: 1, 4, 5].
Strive, Inc. (ASST)
│
┌─────────────────────────────┴─────────────────────────────┐
▼ ▼
Investment Advisory Services Preventative Healthcare
(Strive Asset Management, LLC) (Clinivanta, Inc.)
│ │
├─ 13 Exchange-Traded Funds (ETFs) └─ QuantaFlo Diagnostic Tool
├─ Collective Investment Trusts (CITs) (FDA-cleared vascular flow
└─ Direct Indexing Platforms (Schwab/Fidelity) testing for PAD diagnosis)
The enterprise generates revenue through two primary operating segments [cite: 6, 7]:
| Business Segment | Primary Products & Services | Revenue Generation Mechanism |
|---|---|---|
| Investment Advisory | 13 Exchange-Traded Funds (ETFs), Collective Investment Trusts (CITs), and direct indexing platforms managed by Strive Asset Management, LLC [cite: 1, 8]. | Investment advisory fees based on a percentage of Assets Under Management (AUM), currently exceeding $\$2.5$ billion [cite: 6, 9]. |
| Preventative Healthcare | QuantaFlo, an FDA-cleared point-of-care medical diagnostic tool that measures arterial blood flow to aid in diagnosing peripheral arterial disease (PAD) [cite: 5, 10]. | Medical device sales and licensing fees to healthcare systems, insurance providers, and physician groups under Clinivanta (formerly Semler Scientific) [cite: 5, 11, 12]. |
Strive's geographical operations are concentrated within the United States, serving retail wealth management clients, institutional investors, and clinical healthcare networks [cite: 1, 11, 13]. The primary customer segments for the asset management division are individual investors and wealth managers seeking investment products that exclude environmental, social, and governance (ESG) filters, prioritizing shareholder primacy and "unapologetic capitalism" [cite: 14, 15, 16].
The primary customers for the medical diagnostics division are risk-bearing health insurers, integrated delivery networks, and independent physician groups seeking to improve patient screening for cardiovascular disease [cite: 11]. Customers choose Strive's financial products over legacy alternatives due to the company's clear corporate governance stance and proxy voting strategies [cite: 1]. Equity allocators choose ASST common stock as a leveraged corporate proxy to Bitcoin, utilizing a "preferred-equity-only" capital model designed to grow Bitcoin per share while avoiding traditional debt maturity defaults [cite: 17, 18].
Strive's primary strategic objective is to outperform Bitcoin over the long term by utilizing its operating business cash flows and preferred equity issuance to steadily accumulate digital assets [cite: 2, 19]. The fundamental drivers of the business are twofold: scaling the traditional investment advisory platform to generate recurring fee income and executing capital market operations to expand its physical Bitcoin treasury [cite: 6, 20].
The cornerstone of Strive's capital structure is its Variable Rate Series A Perpetual Preferred Stock (SATA), which trades on Nasdaq and is designed to pay a 13.00% annualized dividend distributed to shareholders every business day [cite: 21]. SATA allows Strive to raise non-dilutive capital, which is immediately deployed into physical Bitcoin [cite: 19, 20]. Management uses Bitcoin as its hurdle rate for capital deployment, attempting to generate accretive "Bitcoin Yield" (growth in Bitcoin holdings relative to diluted common shares outstanding) to increase long-term common equity value [cite: 7, 20, 22].
SATA Preferred Capital Loop
┌──────────────────┐ SATA Issuance ┌──────────────────┐ Bitcoin Purchase
│ Retail & Institutional ├───────────────►│ Strive, Inc. ├───────────────► 23,156 BTC
│ Income Investors │ At $100 Par │ Treasury Pool │ Held in Cold Storage
└────────▲─────────┘ └────────┬─────────┘ │
│ │ │
└──────────────────────────────────────────┴──────────────────────────┘
13.00% Annual Yield Paid Daily
Strive's business model is protected by several competitive entry barriers:
* Brand Equity and Ideological Positioning: Founded with an explicit anti-ESG mandate, Strive has built a brand identity focused on shareholder primacy [cite: 1, 16]. This branding serves as a customer acquisition channel, capturing retail and institutional assets that are less sensitive to fee levels, which helps protect Strive from the fee compression seen across the broader ETF industry [cite: 1, 15].
* Vascular Diagnostic Patent Lock: Clinivanta holds patented, FDA-cleared QuantaFlo intellectual property [cite: 5, 10]. This point-of-care system has high switching costs because it is integrated directly into the clinical workflows and diagnostic billing databases of major Medicare Advantage insurers [cite: 11].
* Direct Indexing Infrastructure: The firm's direct indexing services, integrated with Fidelity and Charles Schwab, leverage established custody and clearing networks [cite: 1]. This infrastructure provides retail investors with customized tax-loss harvesting and proxy voting capabilities, creating structural switching costs for wealth management advisory platforms [cite: 1].
* Capital Structure Innovation: The SATA preferred share ecosystem represents a unique structural advantage over debt-leveraged peers [cite: 17, 18]. Because SATA is a perpetual preferred stock with no maturity dates or debt covenants, Strive is insulated from insolvency risks during severe digital asset bear markets, allowing the treasury to remain intact [cite: 17, 18, 21].
Strive's addressable market spans asset management, corporate treasury yield products, and preventative diagnostics [cite: 6, 11, 20]:
| Industry Segment | Metric / TAM Valuation | Primary Driver |
|---|---|---|
| Traditional Asset Management | $\$110+$ Trillion (Global AUM Pool) | Market share shifts from passive funds to actively managed, non-ESG, and customized direct-indexing accounts [cite: 1, 15]. |
| Digital Credit & Alternative Yield | $\$2+$ Trillion | Growth of alternative yield-bearing cash-management corporate reserves seeking to hedge inflation [cite: 20]. |
| Preventative Healthcare Diagnostics | $\$15+$ Billion (Chronic Vascular Disease) | Demographic aging in the U.S. and clinical emphasis on early cardiovascular risk screening [cite: 10, 11]. |
Strive competes in two distinct markets: traditional asset management and corporate digital asset treasuries [cite: 1, 3]. In the asset management space, the company faces scale competition from institutional giants like BlackRock, Vanguard, and State Street [cite: 19, 23]. Strive differentiates its products by committing to voice-based shareholder activism and anti-ESG corporate governance, attracting investors who feel underserved by mainstream asset managers [cite: 1, 15].
In the digital asset treasury market, Strive's main competitor is MicroStrategy Inc. (Strategy, Inc.) [cite: 20, 24]. Strive is positioned as a lower-risk option compared to MicroStrategy’s debt-financed model [cite: 11, 17]. By avoiding traditional debt and using a "preferred-equity-only" capital model, Strive eliminates the risk of refinancing or margin liquidation [cite: 17, 18].
Additionally, Strive has integrated its capital structure with its competitor's by acquiring a $\$48.0$ million position in Strategy Inc.'s Variable Rate Series A Perpetual Preferred Stock (STRC) [cite: 24, 25]. This holding provides Strive with high-yield income while strengthening its own cash reserves [cite: 20].
Strive, Inc. announced its second quarter 2026 financial results for the period ended June 30, 2026, on August 10, 2026 [cite: 6, 24]. The results show growth in operating revenues alongside GAAP accounting net losses, which were driven by the mark-to-market valuation of its digital asset treasury [cite: 7].
During the three months ended June 30, 2026, Strive generated total revenues of $\$2.94$ million, representing a $94.6\%$ year-over-year increase compared to the $\$1.51$ million reported in Q2 2025 [cite: 6, 7].
Operating expenses rose to $\$24.40$ million, compared to $\$5.20$ million in Q2 2025 [cite: 24]. This increase was primarily driven by higher compensation and administrative costs to support public market reporting, corporate restructuring, and Bitcoin custody fees [cite: 6, 25, 26]. Specifically, employee compensation and benefits rose to $\$16.31$ million (including $\$5.7$ million in non-cash stock-based compensation), and general and administrative expenses rose to $\$6.43$ million [cite: 24, 26].
Total Revenues Mix (Q2 2026)
┌───────────────────────────────┐
│ ███████████████ 51.4% │ Investment Advisory Fees
│ ░░░░░░░░░░░░░░ 47.3% │ Medical Device Revenues
│ ▓ 1.3% │ Other Revenue
└───────────────────────────────┘
The company reported a GAAP net loss of $\$257.60$ million for the quarter, compared to a net loss of $\$8.88$ million in Q2 2025 [cite: 6, 7]. The widened net loss was driven by non-operating accounting adjustments rather than core operational declines:
* A net unrealized loss on digital assets of $\$228.03$ million, reflecting the quarterly mark-to-market valuation of its Bitcoin holdings [cite: 7, 24].
* A net unrealized loss on preferred equity investments of $\$5.96$ million, stemming from its holding of STRC preferred stock [cite: 24, 25].
Dividends declared on its SATA preferred stock totaled $\$26.21$ million during the quarter [cite: 7, 24]. When accounting for these preferred dividends, the GAAP net loss attributable to common stockholders was $\$283.81$ million, resulting in basic and diluted EPS of $\dotso$ [cite: 6, 7, 24].
On a non-GAAP adjusted basis, the net loss attributable to common stockholders was $\$275.00$ million (or $\$(3.65)$ per diluted common share), after adjusting for share-based compensation, transaction costs, and changes in the fair value of its debt [cite: 7, 24]. Of this adjusted loss, $\$234.00$ million ($85.1\%$) was due to paper declines in Bitcoin and STRC valuations [cite: 24, 25].
Strive’s balance sheet expanded significantly over the first half of 2026 [cite: 7, 25]. As of June 30, 2026, total assets reached $\$1.38$ billion, up from $\$745.53$ million on December 31, 2025 [cite: 24, 25].
* Digital Assets (at Fair Value): Valued at $\$1.16$ billion as of June 30, 2026, compared to $\$668.49$ million at the end of 2025 [cite: 7, 24, 25].
* Cash and Cash Equivalents: Stood at $\$154.90$ million as of August 7, 2026 [cite: 7, 25].
* Strategic Investments: Held $\$48.00$ million in STRC preferred stock [cite: 24, 25].
* Long-Term Debt: The company fully retired all short-term and long-term notes payable by August 7, 2026, leaving it completely debt-free [cite: 7, 24, 25].
* Capital Structure: As of August 7, 2026, Strive’s outstanding capital included 75,649,368 Class A common shares, 9,792,535 Class B common shares, and 7,829,502 shares of SATA preferred stock [cite: 24, 25].
Strive's Q2 2026 financial results missed analyst consensus expectations. Revenue of $\$2.94$ million missed estimates by $2.72\%$ ($\$3.02$ million expected) [cite: 22, 27]. Diluted EPS of $\$(3.77)$ fell significantly short of expectations due to the unrealized paper decline of its Bitcoin holdings under GAAP fair value accounting rules [cite: 6, 22, 28].
The company did not issue forward-looking financial earnings guidance. However, consensus expectations shifted, with the forecast breakeven year pushed from fiscal year 2026 to fiscal year 2027 [cite: 22, 28]. Management updated its strategic operating parameters, narrowing its long-term target trading price range for SATA preferred stock to $\$99.00-\$101.00$ per share and confirming it will not issue SATA shares through at-the-market (ATM) programs below its $\$100.00$ par value [cite: 20, 29].
During its recent announcements, management highlighted several key strategic areas:
* Digital Credit Expansion: CEO Matt Cole noted that digital credit presents a multi-trillion-dollar addressable market, and that the company is focused on establishing a stable trading history for SATA to build institutional confidence [cite: 20].
* Bitcoin Accumulation Goal: The executive team reiterated its target of ending 2026 as the world's second-largest publicly traded corporate holder of Bitcoin [cite: 30, 31].
* Healthcare Asset Monetization: Chief Strategy Officer Avik Roy is tasked with expanding Clinivanta’s preventative care footprint, with plans to potentially monetize or distribute the diagnostics business to unlock additional capital [cite: 5, 10, 11].
Despite the GAAP net losses reported on August 10, 2026 [cite: 24, 25], subsequent disclosures of aggressive open-market Bitcoin purchases triggered a significant rally in the stock [cite: 31, 32, 33]. Between August 24 and August 28, 2026, the company acquired 1,800 Bitcoin for $\$143.00$ million, bringing its total holdings to 23,156 BTC [cite: 31, 33]. This announcement drove a $119.76\%$ rise in the share price over the trailing 30-day period ending September 4, 2026, with the stock closing at $\$27.14$ [cite: 19, 31].
Following these developments, major research firms revised their outlooks:
* TD Cowen: Maintained its Buy rating and raised its price target to $\$32.00$ from $\$28.00$, citing treasury growth that outpaced its initial forecasts [cite: 30, 31].
* B. Riley Securities: Upgraded its price target to $\$26.00$ from $\$16.00$, maintaining a Buy recommendation [cite: 34].
* HC Wainwright & Co.: Established a high consensus price target of $\$38.00$ [cite: 31, 32].
Traditional valuation metrics like enterprise value to sales ($333.64\text{x}$ TTM EV/Sales) [cite: 4, 35] and price to sales ($15.23\text{x}$) [cite: 36] are less useful for Strive due to the size of its digital asset treasury relative to its operating business [cite: 7]. The core metric for valuing the common equity is its premium to modified Net Asset Value (mNAV) [cite: 22].
The modified Net Asset Value is calculated as follows:
$\text{mNAV} = \text{Bitcoin Value} + \text{Cash Equivalents} + \text{STRC Fair Value} - \text{SATA Preferred Redemption Liability}$
Applying late-August 2026 prices (with Bitcoin at $\$79,431$ [cite: 33] and SATA preferred stock outstanding at $9.07$ million shares [cite: 33]), Strive’s underlying asset values are summarized below:
| Balance Sheet Component | Value | Metric Source |
|---|---|---|
| Bitcoin Treasury (23,156 BTC at $\$79,431$/BTC) | $\$1,839.30$ Million | [cite: 33] |
| Cash and Cash Equivalents | $\$183.50$ Million | [cite: 33] |
| STRC Preferred Equity Position | $\$49.20$ Million | [cite: 33] |
| Gross Financial Assets | $\$2,072.00$ Million | [cite: 33] |
| SATA Preferred Stock Liability (At $\$100$ Redemption Par) | $(\$907.39)$ Million | [cite: 33] |
| Net Asset Value (Common Equity Portion) | $\$1,164.61$ Million | [cite: 33] |
Given its market capitalization of $\$2.43$ billion as of early September 2026 [cite: 19, 37], the common stock trades at a premium to mNAV of:
$\text{mNAV Premium} = \frac{\$2,430.00\text{ Million}}{\$1,164.61\text{ Million}} \approx 2.09\text{x}$
This valuation premium is supported by the company’s ability to generate "Bitcoin Yield" through its SATA preferred equity program without dilution to common shareholders [cite: 7, 22]. Over a 5-year horizon, the common stock's valuation remains highly sensitive to both the long-term compounding of asset management fees (projected at a 15% CAGR) and the trajectory of Bitcoin prices [cite: 22].
Strive's hybrid model exposes the company to operational, regulatory, and market risks across financial services, digital asset management, and healthcare diagnostics [cite: 1, 6, 38].
The primary execution risk is Strive's ability to maintain net capital inflows into its non-ESG, thematic, and index investment funds [cite: 1, 15, 16]. The anti-ESG space remains a niche market, and a failure to sustain organic client acquisition could reduce advisory fee revenues and affect operational scaling [cite: 15, 16, 23].
Operational risks also extend to the healthcare division, where Strive must manage and potentially divest or monetize Clinivanta’s diagnostic assets [cite: 5, 11]. This effort requires steady clinical adoption of the QuantaFlo system under new management and the successful rollout of broader preventative health products [cite: 5, 10, 18].
Competitive risks are driven by both traditional and digital asset peers:
* Asset Management Peers: Larger institutional asset managers (e.g., BlackRock, Vanguard) could lower fees on their own alternative or anti-activism funds [cite: 1, 19]. This price competition could reduce Strive's market share and pressure fees across its core ETF suites [cite: 1].
* Bitcoin Treasury Peers: Competitors like Strategy Inc. may launch their own yield-bearing preferred shares [cite: 20, 39]. If other players offer competing corporate cash-management tools, Strive's relative yield advantage and its ability to raise capital via SATA could be impacted [cite: 13, 21, 40].
The medical diagnostics segment faces high customer concentration, as its diagnostic software revenues are linked to a small number of large U.S. healthcare payers and integrated delivery networks [cite: 11].
If any major insurance client modifies its vascular diagnostic screening protocols, or if Medicare Advantage coverage policies change, Clinivanta's operating cash flows could experience declines [cite: 10, 11].
Strive operates under multiple complex regulatory frameworks:
* Tax Status of Swaps: Strive relies on Section 351 of the Internal Revenue Code to structure tax-free exchanges of Bitcoin for public equity [cite: 41, 42]. Any adverse changes by the IRS regarding this tax classification would disrupt a key channel for Strive's Bitcoin accumulation strategy [cite: 41, 42].
* SEC Scrutiny of Yield Products: The daily cash distribution structure of its SATA preferred stock on Nasdaq represents a unique market offering [cite: 21, 40]. If the SEC introduces new restrictions on daily preferred distributions or at-the-market preferred stock issuances, Strive’s capital-raising model could be impacted [cite: 13, 21].
Strive Regulatory & Capital Exposure Matrix
┌────────────────────────────────────────────────────────┐
│ SEC: Daily Liquidity Mechanics & SATA Distributions │ High Scrutiny Risk
├────────────────────────────────────────────────────────┤
│ IRS: Section 351 Tax-Deferred Swap Status │ Structural Risk
├────────────────────────────────────────────────────────┤
│ HHS/CMS: Medicare Advantage Reimbursement Policies │ Cash Flow Sensitivity
└────────────────────────────────────────────────────────┘
Strive’s balance sheet is highly sensitive to the valuation of its Bitcoin holdings [cite: 7, 25]. Large GAAP accounting write-downs during crypto market drawdowns can negatively affect investor sentiment and elevate its cost of capital [cite: 7, 23].
Additionally, the commitment to pay a 13.00% daily dividend on its SATA preferred stock represents a fixed cash outflow [cite: 21, 25]. While Strive maintains cash and STRC preferred reserves, a prolonged drop in Bitcoin prices could force the company to fund these dividend obligations by selling asset management holdings or issuing dilutive Class A common stock [cite: 9, 20].
The asset management sector is characterized by ongoing fee compression and rising compliance costs [cite: 1].
At the same time, the medical diagnostics industry faces stringent clinical validation requirements and lengthy FDA product clearance cycles, which can delay the commercialization of new diagnostic offerings [cite: 5, 10, 11].
Strive is exposed to shifts in interest rates and macroeconomic policy:
* Interest Rate Fluctuations: A persistent high-rate environment increases the yields offered by lower-risk instruments like U.S. Treasuries, which could reduce the relative appeal of SATA’s 13.00% yield to income-focused investors [cite: 9, 21].
* Federal Reserve Monetary Policy: Changes in central bank liquidity directly influence global digital asset valuations [cite: 31]. Federal Reserve rate hikes or monetary tightening cycles can trigger pullbacks in Bitcoin, directly impacting Strive’s net asset value and share price [cite: 31].
The 5-year valuation model for Strive, Inc. utilizes an asset-backed net asset value approach, connecting the common stock price to the projected growth of its Bitcoin treasury, capital structure costs, and operating division cash flows [cite: 22].
This case assumes Bitcoin appreciates to $\$200,000$ by Year 5, driven by steady institutional adoption. Strive continues its treasury expansion through controlled SATA preferred issuances and ATM program activity, growing its holdings to 60,000 BTC.
* Investment Advisory AUM: Scales to $\$8.00$ billion, generating $\$25.00$ million in annual advisory revenue [cite: 11].
* Preventative Healthcare Division: Successfully monetized, contributing $\$15.00$ million in annual revenues [cite: 11].
* Operating EBITDA: Becomes profitable, reaching $\$10.00$ million.
* SATA Preferred Outstanding: Reaches $20.00$ million shares, representing a $\$2.00$ billion redemption par liability [cite: 13].
* Common Net Asset Value Calculation:
$\text{Common NAV} = (60,000\text{ BTC} \times \$200,000) + \$500.00\text{ Million (Cash \& STRC)} - \$2.00\text{ Billion (SATA Liability)} = \$10.50\text{ Billion}$
This case assumes a major digital asset bull market, with Bitcoin reaching $\$400,000$ by Year 5. Strive expands its treasury holdings to 100,000 BTC through global distribution of its SATA daily-dividend program.
* Investment Advisory AUM: Reaches $\$15.00$ billion, generating $\$55.00$ million in annual advisory revenue [cite: 9].
* Healthcare Division: Contributes $\$20.00$ million in annual preventative care revenue [cite: 5, 43].
* Operating EBITDA: Reaches $\$35.00$ million.
* SATA Preferred Outstanding: Scales to $40.00$ million shares, representing a $\$4.00$ billion redemption par liability [cite: 13].
* Common Net Asset Value Calculation:
$\text{Common NAV} = (100,000\text{ BTC} \times \$400,000) + \$1.00\text{ Billion (Cash \& STRC)} - \$4.00\text{ Billion (SATA Liability)} = \$37.00\text{ Billion}$
This case assumes a prolonged digital asset downturn, with Bitcoin falling to and stagnating at $\$50,000$ by Year 5. Regulatory challenges or capital constraints restrict SATA offerings, stopping new treasury acquisitions.
* Investment Advisory AUM: Contracts to $\$1.50$ billion, generating $\$5.00$ million in annual revenue [cite: 1, 12].
* Healthcare Division: Reimbursement cuts reduce clinical diagnostic revenues to $\$3.00$ million [cite: 11].
* Operating EBITDA: Remains unprofitable at $\$(2.00)$ million.
* SATA Preferred Outstanding: Represents $15.00$ million shares outstanding ($\$1.50$ billion redemption liability) [cite: 13].
* Common Net Asset Value Calculation:
$\text{Common NAV} = (25,000\text{ BTC} \times \$50,000) + \$100.00\text{ Million (Cash)} - \$1.50\text{ Billion (SATA Liability)} = -\$150.00\text{ Million}$
| Scenario | Revenue / Key Scale Metric in Year 5 | Margin / Earnings Assumption | Valuation Multiple Assumption | Current Share Price (USD) | Implied Future Share Price (USD) | 5-Year Total Return | Annualized Return | Probability |
|---|---|---|---|---|---|---|---|---|
| High Case | $100,000\text{ BTC} / \$15.0\text{B}$ | $\$35\text{M EBITDA}$ | $1.45\text{x mNAV}$ | $\$27.14$ | $\$153.29$ | $+464.8\%$ | $+41.4\%$ | $25\%$ |
| Base Case | $60,000\text{ BTC} / \$8.0\text{B}$ | $\$10\text{M EBITDA}$ | $1.10\text{x mNAV}$ | $\$27.14$ | $\$46.20$ | $+70.2\%$ | $+11.2\%$ | $50\%$ |
| Low Case | $25,000\text{ BTC} / \$1.5\text{B}$ | $\$(2)\text{M EBITDA}$ | Recovery Value | $\$27.14$ | $\$1.33$ | $-95.1\%$ | $-45.4\%$ | $25\%$ |
$\text{Probability-Weighted Share Price Target} = (0.25 \times \$153.29) + (0.50 \times \$46.20) + (0.25 \times \$1.33) = \$61.75\text{ USD}$
ASYMMETRIC VOLATILE PROXY
To evaluate the operational strength and risk profile of Strive, Inc. as an investment vehicle, the key aspects of its business model have been rated on a scale from 1 to 10 (with 10 representing optimal performance):
HIGH-RISK SPECULATIVE STRUCTURE
Strive, Inc. represents an unconventional public corporate vehicle that combines traditional asset management and medical diagnostics divisions with a leveraged Bitcoin accumulation model [cite: 3, 5, 6]. By using its daily-dividend SATA preferred stock to fund open-market purchases, the company has built a treasury of 23,156 Bitcoin as of late August 2026, positioning itself as a major corporate holder [cite: 24, 33].
The long-term investment thesis relies on Strive's ability to maintain its "preferred-equity-only" model to drive share value accretion without the solvency risks of traditional debt leverage [cite: 17, 18]. Key catalysts to monitor include:
* Continued asset inflows into Strive’s anti-ESG and thematic ETF suites [cite: 1, 16].
* Successful clinical adoption and monetization of Clinivanta’s QuantaFlo vascular screening tool [cite: 5, 10].
* The compounding of "Bitcoin Yield" through the issuance and reinvestment of SATA preferred stock [cite: 7, 22].
However, the stock carries significant risks, primarily its direct exposure to digital asset market volatility, GAAP accounting net losses [cite: 7], and regulatory developments surrounding its tax-deferred share swaps and daily preferred dividend distributions [cite: 21, 41, 42]. Strive’s common stock remains highly sensitive to digital asset valuations, trading at an mNAV premium that reflects both its growth rate and its unique capital structure [cite: 22, 31].
ASYMMETRIC CORRELATION PROXY
Strive's stock has shown strong upward momentum, driven by its ongoing Bitcoin accumulation strategy [cite: 19, 31]. As of early September 2026, the share price closed at $\$27.14$, representing a $119.76\%$ gain over the preceding month and trading above its 200-day moving average [cite: 4, 19, 31].
Price Action
$30 ───────────────────────────────────────────────────────────────
$25 ───────────────────────────────────────────● Current ($27.14)
$20 ───────────────────● 200-Day MA
$15 ───────────────────
$10 ───────────────────
April '26 May '26 June '26 Aug '26 Sept '26
In the near term, the stock's trajectory remains highly sensitive to Bitcoin holding its current levels [cite: 31]. Investors should also monitor upcoming capital structure updates, particularly with the stock trading near its $\$700.00$ million warrant exercise hurdle expiring in mid-October [cite: 1, 31].
SENSITIVE MOMENTUM PLAY
View Strive, Inc. (ASST) stock page
Loading the interactive version of this report…